Innovating Works

ASPHALION

Activa
Mostrando 1 al 20 de 23 resultados
PragmaTIL: Pragmatic approach to Adoptive Cell Therapy (ACT) using Tumor Infiltrating Lymphocytes (TIL) in sele... FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALL-HEBRON tramitó un HORIZON EUROPE: HORIZON-MISS-2022-CANCER-01 The PragmaTIL trial aims to optimize treatment of cancer patients with Tumour-Infiltrating Lymphocytes Adoptive Cell Therapy (TIL-ACT) and s...
2023-04-28 - 2028-03-31 | Financiado
IMMUTOL: ADVANCED ANTIGEN-SPECIFIC DENDRITIC CELL-BASED THERAPY TO RE-ESTABLISH TOLERANCE IN IMMUNE-MEDIATED... FONDAZIONE TELETHON ETS tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-two-stage Autoimmune diseases are currently treated with immunosuppressive and supportive therapies, which dampen inflammation, but do not stop the ca...
2023-04-14 - 2027-04-30 | Financiado
NABIHEAL: ANTIMICROBIAL NANOSTRUCTURED BIOMATERIALS FOR COMPLEX WOUND HEALING CENTRO DE INVESTIGACION BIOMEDICA EN RED CIBER tramitó un HORIZON EUROPE: HORIZON-CL4-2022-RESILIENCE-01 Complex wounds impact the quality of life of more than 2% of total population in developed countries being a global health problem with sign...
2022-11-29 - 2026-12-31 | Financiado
METHYLOMIC: DNA methylation markers to predict treatment success of biologicals in Crohn’s disease. Academisch Medisch Centrum AMC tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-TOOL-11 Monoclonal antibodies have become a mainstay of therapy in common immune-mediated diseases (IMID) including Crohn’s disease (CD), rheumatoid...
2022-11-24 - 2026-12-31 | Financiado
FORCE REPAIR: smart and multiFunctional 3D printable prO Regenerative biologiCal matrix modulating mEchanotRansduc... FUNDACION CIDETEC tramitó un HORIZON EUROPE: HORIZON-CL4-2022-RESILIENCE-01 Due to population lifestyle changes, i.e. obesity, diabetes and aging population, chronic wounds (CW) which fail to follow the typical heali...
2022-11-18 - 2026-12-31 | Financiado
EChiLiBRiST: Development and validation of a quantitative point of care test for the measurement of severity biom... FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 "Fever is the leading reason to seek healthcare globally, with over 1 billion cases of febrile illness occurring in children annually. The v...
2022-07-18 - 2027-08-31 | Financiado
ETERNAL: Boosting the reduction of the environmental impact of pharmaceutical products throughout their entir... AIMPLAS-ASOCIACIÓN DE INVESTIGACIÓN DE MATERIALES PLÁSTICOS Y CONEXAS tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-IND-07 ETERNAL aims to contribute to sustainable development of pharmaceutical manufacture, use and disposal, by using and promoting full life cycl...
2022-05-23 - 2026-08-31 | Financiado
SINPAIN: A game changer for the treatment of osteoarthritis: a cost effective combined advanced therapy to tr... FUNDACION CIDETEC tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-TOOL-06 According to the WHO Osteoarthritis (OA) is one major course of years lived with disability in the elderly and considered a high burden dise...
2022-05-19 - 2026-10-31 | Financiado
RBDCOV: RBD Dimer recombinant protein vaccine against SARSCoV2 HIPRA SCIENTIFIC tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-CORONA-01 The main objective of RBDCOV project is to test the efficacy, tolerability, and safety of a new vaccine against different variants of COVID-...
2021-11-12 - 2024-05-31 | Financiado
UroPrint: Urinary bladder bioprinting for fully autologous transplantation IDRYMA IATROVIOLOGIKON EREUNON AKADEMIAS ATHINON tramitó un H2020: H2020-FETOPEN-2018-2020 A number of conditions, including trauma, inflammation, incontinence, overactive bladder, renal impairments, neurological disorders (like sp...
2021-03-12 - 2025-08-31 | Financiado
SPIOMET4HEALTH: PCOS IN ADOLESCENT GIRLS AND YOUNG WOMEN TOWARD A TREATMENT GUIDED BY PATHOPHYSIOLOGY FUNDACIO PRIVADA PER LA RECERCA I LA DOCENCIA SANT JOAN DE DEU tramitó un H2020: H2020-SC1-BHC-2018-2020 Polycystic Ovary Syndrome (PCOS) is the most prevalent, chronic endocrine-metabolic disorder of adolescents and young women (AYAs), affectin...
2021-02-01 - 2026-03-31 | Financiado
IN2SIGHT: AN IN VIVO BIOENGINEERED CHIP AS A SMART INTRAVITAL MULTIPHOTON IMAGING WINDOW FOR NEW VALIDATION PR... UNIVERSITA DEGLI STUDI DI MILANOBICOCCA tramitó un H2020: H2020-FETOPEN-2018-2020 Routine clinical use of biomaterials requires the reduction of the economical and ethical costs of biocompatibility tests (ISO10993 EU norm)...
2020-12-21 - 2025-02-28 | Financiado
ARDAT: Accelerating Research Development for Advanced Therapies THE UNIVERSITY OF SHEFFIELD tramitó un H2020: H2020-JTI-IMI2-2019-18-two-stage Major current hurdles for wide clinical use of AAV vectors are attributable primarily to: (i) host elimination by both immune and non-immune...
2020-11-11 - 2025-10-31 | Financiado
Tumor-LN-oC: Tumor and Lymph Node on Chip for cancer studies EREVNITIKO PANEPISTIMIAKO INSTITOUTO SYSTIMATON EPIKOINONION KAI YPOLOGISTON tramitó un H2020: H2020-NMBP-TR-IND-2018-2020 The lymphatic system and lymph nodes (LNs) are an integral part of our adaptive immune system and many tumors exploit lymphatic vessels to s...
2020-11-06 - 2025-10-31 | Financiado
VASCOVID: PORTABLE PLATFORM FOR THE ASSESSMENT OF MICROVASCULAR HEALTH IN COVID 19 PATIENTS AT THE INTENSIVE C... FUNDACIO INSTITUT DE CIENCIES FOTONIQUES tramitó un H2020: H2020-SC1-PHE-CORONAVIRUS-2020-2 As COVID-19 spreads worldwide, the surge in patients requiring intensive care unit (ICU) admission has been overwhelming to the healthcare s...
2020-09-22 - 2023-05-31 | Financiado
MISTRAL: Microbiome based stratification of individuals at risk of HIV 1 acquisition chronic clinical compli... FUNDACIO PRIVADA INSTITUT DE RECERCA DE LA SIDA-CAIXA tramitó un H2020: H2020-SC1-BHC-2018-2020 The HIV/AIDS pandemic continues to be one of the major health challenges ever faced by mankind. Far from being resolved, HIV is soaring in E...
2019-12-11 - 2025-12-31 | Financiado
SBR: SMART BONE REGENERATION PANEPISTIMIO PATRON tramitó un H2020: H2020-SC1-BHC-2018-2020 The management and reconstruction of bone defects is a significant global healthcare challenge. While autografts offer ideal compatibility,...
2019-11-24 - 2024-12-31 | Financiado
CardioReGenix: CardioReGenix Development of Next Generation Gene Therapies for Cardiovascular Disease VRIJE UNIVERSITEIT BRUSSEL tramitó un H2020: H2020-SC1-BHC-2018-2020 WHO estimates 17.7 million people die each year from cardiovascular disease (CVD), an estimated 31% of all deaths worldwide. While progress...
2018-11-21 - 2024-06-30 | Financiado
nTRACK: Multimodal nanoparticles for structural and functional tracking of stem cell therapy on muscle regen... ACONDICIONAMIENTO TARRASENSE - LEITAT tramitó un H2020: H2020-NMBP-2016-2017 Cell therapy offers promising opportunities to approach several diseases for which no effective therapies are currently available. However,...
2017-10-30 - 2022-03-31 | Financiado
HIVACAR: Evaluating a Combination of Immune based Therapies to Achieve a Functional Cure of HIV Infection FUNDACIO CLINIC PER A LA RECERCA BIOMEDICA tramitó un H2020: H2020-SC1-2016-2017 The main goal of HIVACAR proposal is to change the current paradigm of HIV treatment by obtaining a functional cure for HIV (i.e., control o...
2016-12-12 - 2022-06-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.